Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Assertio Holdings Community
NasdaqCM:ASRT Community
1
Narratives
written by author
0
Comments
on narratives written by author
24
Fair Values set
on narratives written by author
Create a narrative
Assertio Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Assertio Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Rolvedon And Sympazan Will Create New Market Opportunities
Key Takeaways Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth. Streamlining operations and reducing legal expenses strive to improve net margins and operational efficiencies.
View narrative
US$2.85
FV
77.2% undervalued
intrinsic discount
1.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
Your Valuation for
ASRT
ASRT
Assertio Holdings
Your Fair Value
US$
Current Price
US$0.65
75.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-332m
456m
2015
2018
2021
2024
2025
2027
2030
Revenue US$148.1m
Earnings US$22.1m
Advanced
Set Fair Value